Inventor · disambiguated record
Torbjörn Bäckström
Also filed as: BACKSTROM TORBJORN · BAECKSTROEM TORBJOERN · BÄCKSTRÖM TORBJÖRN
16 granted patents·9 pending applications·51 citations·filing 1999–2022
90Inventor score
Files withUMECRINE AB7UMECRINE COGNITION AB7ASARINA PHARMA AB4BACKSTROM TORBJORN2BAECKSTROEM TORBJOERN2
Top patents by PatentIndex Score
25 records- 0181US9200028B2Steroids having increased water solubility and resistance against metabolism and methods for their productionUMECRINE COGNITION AB·Filed 2013·Granted Dec 1, 2015·4 cites·2 claims
- 0279US8580983B2Steroids having increased water solubility and resistance against metabolism, and methods for their productionBAECKSTROEM TORBJOERN·Filed 2007·Granted Nov 12, 2013·4 cites·5 claims
- 0379US8114860B2GABA-steroid antagonists and their use for the treatment of CNS disordersBACKSTROM TORBJORN·Filed 2005·Granted Feb 14, 2012·8 cites·3 claims
- 0476US2023117905A1Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility propertiesASARINA PHARMA AB·Filed 2022·Application pending·0 cites
- 0574US10342804B2Steroid compound for use in the treatment of hepatic encephalopathyUMECRINE COGNITION AB·Filed 2017·Granted Jul 9, 2019·2 cites·20 claims
- 0674US9801894B2Steroid compound for use in the treatment of hepatic encephalopathyUMECRINE COGNITION AB·Filed 2016·Granted Oct 31, 2017·2 cites·27 claims
- 0772US8119619B2Pregnane steroids and their use in the treatment of CNS disordersBAECKSTROEM TORBJOERN·Filed 2011·Granted Feb 21, 2012·3 cites·17 claims
- 0870US8853190B2Steroids having increased water solubility and resistance against metabolism, and methods for their productionUMECRINE AB·Filed 2013·Granted Oct 7, 2014·1 cites·2 claims
- 0968US6455516B1Method and compounds for use in the treatment of steroid induced states of the central nervous systemFiled 1999·Granted Sep 24, 2002·27 cites·4 claims
- 1060US11534446B2Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility propertiesASARINA PHARMA AB·Filed 2017·Granted Dec 27, 2022·0 cites·19 claims
- 1159US2025387409A13-beta-hydroxy-3-alpha-ethyl steroids for modulation of the alpha-3 subtype of the gabaa receptorUMECRINE COGNITION AB·Filed 2022·Application pending·0 cites
- 1257US2024383941A13-alpha substituted 3-beta-hydroxy-17-oximated androstane compound for modulation of the alpha-3 subtype of the gabaa receptorUMECRINE AB·Filed 2022·Application pending·0 cites
- 1356US11026953B23-beta-hydroxy-5-alpha-pregnan-20-one for use in treatment of essential tremorASARINA PHARMA AB·Filed 2018·Granted Jun 8, 2021·0 cites·7 claims
- 1456US2013102579A1Steroids Having Increased Water Solubility and Resistance Against Metabolism and Methods For Their ProductionUMECRINE AB·Filed 2012·Application pending·0 cites
- 1556US2013102578A1New Steroids Having Increased Water Solubility and Resistance Against Metabolism and Methods For Their ProductionUMECRINE AB·Filed 2012·Application pending·0 cites
- 1655US2016272670A1Steroids having increased water solubility and resistance against metabolism and methods for their productionUMECRINE COGNITION AB·Filed 2015·Application pending·0 cites
- 1753US2015315231A1New Steroids Having Increased Water Solubility and Resistance Against Metabolism and Methods For Their ProductionUMECRINE AB·Filed 2015·Application pending·0 cites
- 1850US9687496B2Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility propertiesUMECRINE MOOD AB·Filed 2015·Granted Jun 27, 2017·0 cites·11 claims
- 1950US2021161915A1Gaba-a antagonists for treating substance withdrawal disordersASARINA PHARMA APS·Filed 2019·Application pending·0 cites
- 2049US11026954B23-beta-hydroxy-5-alpha-pregnan-20-one for use in medical treatmentASARINA PHARMA AB·Filed 2018·Granted Jun 8, 2021·0 cites·14 claims
- 2149US2012322781A1Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility propertiesBACKSTROM TORBJORN·Filed 2011·Application pending·0 cites
- 2248US10278977B2Methods for treating hypersomnolenceUMECRINE COGNITION AB·Filed 2017·Granted May 7, 2019·0 cites·10 claims
- 2345US8372824B2GABA-steroid antagonists and their use for the treatment of CNS disordersUMECRINE AB·Filed 2012·Granted Feb 12, 2013·0 cites·6 claims
- 2445US7960367B2Pregnane steroids and their use in the treatment of CNS disordersUMECRINE AB·Filed 2002·Granted Jun 14, 2011·0 cites·19 claims
- 2541US10351589B23.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of CNS disordersUMECRINE COGNITION AB·Filed 2016·Granted Jul 16, 2019·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Torbjörn Bäckström files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →